Skip to content
Recall Observatory FDA recall evidence

Drug product

Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15 mL, Single-dose, Caution: Must Be Diluted, Rx Only, Mfd by Hospira, Inc. Lake Forest, IL 60045 USA, NDC: 0409-7295-01

D-1046-2017

June 15, 2017

Class II

Product summary

Firm
Hospira a Pfizer Company
Event
Event 77533
Status
Terminated
Classification
Class II
Quantity
20,337,650 15 mL single dose vials
Official record key
drug-enforcement:D-1046-2017

Official wording

Reason: Lack of Sterility Assurance

Code information: Lot: 74119EV Exp. 02/01/2019 Lot: 74120EV Exp. 02/01/2019 Lot: 74121EV Exp. 02/01/2019 Lot: 74307EV Exp. 02/01/2019 Lot: 75326EV Exp. 03/01/2019 Lot: 75327EV Exp. 03/01/2019 Lot: 75215EV Exp. 03/01/2019

Distribution pattern: U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Sterility